Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2014 2
2015 4
2016 4
2017 7
2018 1
2019 3
2020 7
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean pedraza l[au] (86 results)?
HERC Ubiquitin Ligases in Cancer.
Sala-Gaston J, Martinez-Martinez A, Pedrazza L, Lorenzo-Martín LF, Caloto R, Bustelo XR, Ventura F, Rosa JL. Sala-Gaston J, et al. Among authors: pedrazza l. Cancers (Basel). 2020 Jun 22;12(6):1653. doi: 10.3390/cancers12061653. Cancers (Basel). 2020. PMID: 32580485 Free PMC article. Review.
Exenatide induces autophagy and prevents the cell regrowth in HepG2 cells.
Krause GC, Lima KG, Levorse V, Haute GV, Gassen RB, Garcia MC, Pedrazza L, Donadio MVF, Luft C, de Oliveira JR. Krause GC, et al. Among authors: pedrazza l. EXCLI J. 2019 Jul 22;18:540-548. doi: 10.17179/excli2019-1415. eCollection 2019. EXCLI J. 2019. PMID: 31611738 Free PMC article.
CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence.
da Silva EFG, Lima KG, Krause GC, Haute GV, Pedrazza L, Catarina AV, Gassen RB, de Souza Basso B, Dias HB, Luft C, Garcia MCR, Costa BP, Antunes GL, Basso LA, Donadio MVF, Machado P, de Oliveira JR. da Silva EFG, et al. Among authors: pedrazza l. Invest New Drugs. 2020 Dec;38(6):1653-1663. doi: 10.1007/s10637-020-00941-2. Epub 2020 May 4. Invest New Drugs. 2020. PMID: 32367200
31 results